We recently published a list of Jim Cramer Rediscovers Love For Magnificent 7 & Discusses These 11 Stocks In this article, we are going to take a look at where Ford Motor Company (NYSE:F) stands against other stocks that Jim Cramer discusses. In his …
Booking Holdings recently adjusted its underwriting team for a €493 million fixed-income offering, a decision that aligns with the company’s price move of 21% over the past month. This strategic reshuffling, alongside the launch of Priceline's new AI-infused travel tools, appears to support its …
We came across a bullish thesis on electroCore, Inc. (ECOR) on Twitter by KyleAdamsStocks. In this article, we will summarize the bulls’ thesis on ECOR. electroCore, Inc. (ECOR)'s share was trading at $6.85 as of May 2nd.Worst States for Doctors to Practice Medicine wavebreakmedia/Shutterstock.com …
We recently published a list of Jim Cramer Rediscovers Love For Magnificent 7 & Discusses These 11 Stocks In this article, we are going to take a look at where Domino’s Pizza, Inc. (NASDAQ:DPZ) stands against other stocks that Jim Cramer discusses. In his …
PepsiCo recently entered into a multi-year agreement with Amazon Web Services to accelerate digital transformation through cloud and AI advancements, while announcing a 5% increase in its quarterly dividend to $1.42 per share. Despite these promising developments, the company's share price slipped by 3% …
Marvell Technology recently experienced a 24% price increase over the last month, likely influenced by its reaffirmed revenue guidance of $1.875 billion for fiscal 2026, with a tighter range of ±2%. The departure of key executives and board members, alongside advancements in technology such …
As the U.S. market navigates mixed signals from economic indicators and awaits crucial decisions on interest rates and tariffs, investors are keenly observing how these factors impact small-cap stocks, often seen as barometers of domestic economic health. In this dynamic environment, identifying promising yet …
Biogen appointed multiple co-lead underwriters for two fixed-income offerings totaling over $1 billion, showcasing its efforts to bolster financial offerings. This move, coupled with Biogen's recent earnings announcement, which reported a decline in net income and sales but an increase in revenue, did not …
Wall Street analysts are expecting earnings-per-share of $1.44, up 114% from last year, on revenue of $1.4 billion, up 31%. AppLovin’s questions headed into earnings are headlined by a series of short seller reports in the first quarter. AppLovin stock is down 20% since …
Gilead Sciences announced positive data regarding Livdelzi for PBC and bulevirtide for chronic HDV, underscoring progress in liver disease treatment. During the last quarter, the company also reported Q1 financial results, announced positive outcomes for Trodelvy in cancer treatment, and shared updates on strategic …